Genakumab

· Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Genakumab, covering 2024-11-08 to 2025-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults [Phase 1]